Phenoxybenzamine Hydrochloride Capsule
Product Images NDC 72603-229

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenoxybenzamine Hydrochloride (NDC 72603-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Phenoxybenzamine Fig1)

Fig1 (Phenoxybenzamine Fig1)
This is a pharmaceutical product description for capsules containing Phenoxybenzamine hydrochloride USP 10 mg. The capsules are manufactured by APL Health Catg in India and should be stored at controlled room temperature. Each bottle contains 100 capsules and the expiration date is listed as 12/2023. The product information includes details on dosage, storage conditions, manufacturer information, and labeling requirements.*
FDA Label Image

Str (Phenoxybenzamine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.